Ortin Laboratories Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 22.94 million compared to INR 765.17 million a year ago. Revenue was INR 23.3 million compared to INR 767.05 million a year ago. Net income was INR 0.538 million compared to INR 21.23 million a year ago. Basic earnings per share from continuing operations was INR 0.07 compared to INR 2.6042 a year ago. Diluted earnings per share from continuing operations was INR 0.07 compared to INR 2.6042 a year ago. For the six months, sales was INR 42.78 million compared to INR 1,552.39 million a year ago. Revenue was INR 43.15 million compared to INR 1,554.43 million a year ago. Net income was INR 1.45 million compared to INR 22.97 million a year ago. Basic earnings per share from continuing operations was INR 0.18 compared to INR 2.8333 a year ago. Diluted earnings per share from continuing operations was INR 0.18 compared to INR 2.8333 a year ago.